| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate |
2000-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21ae1aea96255a83241ebee7eb9c3a0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fc2322ea8df05aa95bbca73190eefd6 |
| publicationDate |
2005-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2239954-T3 |
| titleOfInvention |
THERAPY AGAINST MELANOMA. |
| abstract |
Use of pegylated interferon-alpha for the manufacture of a medicament for the treatment of a patient who has melanoma that has been surgically removed, wherein said medication is administered to said patient, at a therapeutically effective dose of pegylated interferon-alpha, during a sufficient period to increase progression-free survival time. |
| priorityDate |
1999-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |